Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
ITGAM overexpression + LAG3 overexpression
i
Other names:
ITGAM, CD11B, CR3A, MAC-1, Integrin, alpha M (complement component 3 receptor 3 subunit), LAG3, Lymphocyte Activating 3, Lymphocyte Activation Gene 3 Protein, Lymphocyte-Activation Gene 3, CD223 Antigen, CD223, LAG-3, FDC
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
3902
;
3684
Related biomarkers:
Expression
Mutation
Others
‹
LAG3 expression (6)
LAG3 overexpression (5)
LGALS1 overexpression + LAG3 overexpression (2)
LAG3 expression + CTAG1B expression (1)
LAG3 positive + CD4 positive (1)
PD-L1 overexpression + LAG3 expression + CTAG1B expression (1)
ITGAM expression (1)
ITGAM overexpression + CTLA4 overexpression (1)
PD-L1 expression + LAG3 expression (0)
LAG3 expression (6)
LAG3 overexpression (5)
LGALS1 overexpression + LAG3 overexpression (2)
LAG3 expression + CTAG1B expression (1)
LAG3 positive + CD4 positive (1)
PD-L1 overexpression + LAG3 expression + CTAG1B expression (1)
ITGAM expression (1)
ITGAM overexpression + CTLA4 overexpression (1)
PD-L1 expression + LAG3 expression (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
ITGAM overexpression + LAG3 overexpression
Gastric Cancer
ITGAM overexpression + LAG3 overexpression
Gastric Cancer
nivolumab
Sensitive: C3 – Early Trials
nivolumab
Sensitive
:
C3
nivolumab
Sensitive: C3 – Early Trials
nivolumab
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.